Jenburkt Pharmaceuticals Ltd.
BSE: 524731 |
Sector: Health care |
NSE: N.A. |
ISIN Code: INE354A01013 |
BSE
00:00 | 12 Aug
|
552.80
|
3.50 (0.64%)
|
OPEN
553.95
|
HIGH
558.60
|
LOW
542.00
|
NSE
05:30 | 01 Jan
|
Jenburkt Pharmaceuticals Ltd
|
OPEN |
553.95 |
PREVIOUS CLOSE |
549.30 |
VOLUME |
1800 |
52-Week high |
699.70 |
52-Week low |
452.00 |
P/E |
10.75 |
Mkt Cap.(Rs cr) |
254 |
Buy Price |
0.00 |
Buy Qty |
0.00 |
Sell Price |
0.00 |
Sell Qty |
0.00 |
OPEN |
|
PREVIOUS CLOSE |
|
VOLUME |
|
52-Week high |
0.00 |
52-Week low |
0.00 |
P/E |
10.75 |
Mkt Cap.(Rs cr) |
254 |
Buy Price |
|
Buy Qty |
|
Sell Price |
|
Sell Qty |
|
OPEN |
553.95 |
CLOSE |
549.30 |
VOLUME |
1800 |
52-Week high |
699.70 |
52-Week low |
452.00 |
P/E |
10.75 |
Mkt Cap.(Rs cr) |
254 |
Buy Price |
0.00 |
Buy Qty |
0.00 |
Sell Price |
0.00 |
Sell Qty |
0.00 |
OPEN |
|
PREVIOUS CLOSE |
|
VOLUME |
|
52-Week high |
0.00 |
52-Week low |
0.00 |
P/E |
10.75 |
Mkt Cap.(Rs cr) |
253.74 |
Buy Price |
|
Buy Qty |
|
Sell Price |
|
Sell Qty |
|
Jenburkt Pharmaceuticals Ltd. (JENBURKTPHARMA) - Share Holding
(in %) |
Jun 2022 |
Mar 2022 |
Dec 2021 |
Sep 2021 |
Jun 2021 |
Promoter & Group |
Foreign |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Indian |
45.73 |
45.73 |
45.73 |
45.73 |
45.73 |
Total Promoters |
45.73 |
45.73 |
45.73 |
45.73 |
45.73 |
Non Promoter |
Institutions |
4.37 |
4.37 |
4.37 |
4.37 |
4.37 |
Financial Institutions / Banks |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Foreign Institutional Investors |
4.37 |
4.37 |
4.37 |
4.37 |
4.37 |
Insurance Companies |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Mutual Funds / UTI |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Non-Institution |
49.90 |
49.90 |
49.90 |
49.90 |
49.90 |
Indian Public |
41.33 |
41.28 |
41.55 |
42.80 |
42.78 |
Others |
8.57 |
8.62 |
8.35 |
7.10 |
7.12 |
Total Non Promoter |
54.27 |
54.27 |
54.27 |
54.27 |
54.27 |
Total Promoter & Non Promoter |
100.00 |
100.00 |
100.00 |
100.00 |
100.00 |
Custodians |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Grand Total |
100.00 |
100.00 |
100.00 |
100.00 |
100.00 |
Quick Links for Jenburkt Pharmaceuticals: